The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis

OBJECTIVE: To investigate the efficacy and acceptability of antidepressants in the treatment of generalized anxiety disorder. METHODS: All randomized controlled trials assessing the use of antidepressants in generalized anxiety disorder up to may 2002 were included. Non randomized trials and those that included patients with both generalized anxiety disorder and another Axis I co-morbidity were excluded. Relative risks, weighted mean difference and number needed to treat were estimated. People who died or dropped out were regarded as having had no improvement. RESULTS: Antidepressants (imipramine, venlafaxine and paroxetine) were found to be superior to placebo in treating generalized anxiety disorder. The calculated number needed to treat for antidepressants in generalized anxiety disorder was 5.15. Dropout rates did not differ between antidepressants and placebo. CONCLUSION: The available evidence suggests that antidepressants would probably be a reasonable treatment for generalized anxiety disorder patients in the clinical context.

Saved in:
Bibliographic Details
Main Authors: Schmitt,Ricardo, Gazalle,Fernando Kratz, Lima,Maurício Silva de, Cunha,Ângelo, Souza,Juliano, Kapczinski,Flávio
Format: Digital revista
Language:English
Published: Associação Brasileira de Psiquiatria 2005
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462005000100007
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1516-44462005000100007
record_format ojs
spelling oai:scielo:S1516-444620050001000072005-04-14The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysisSchmitt,RicardoGazalle,Fernando KratzLima,Maurício Silva deCunha,ÂngeloSouza,JulianoKapczinski,Flávio Anxiety disorders/drug therapy Antidepressive agents/therapeutic use Randomized controlled trials Review, academic [Publication type] Meta-analysis OBJECTIVE: To investigate the efficacy and acceptability of antidepressants in the treatment of generalized anxiety disorder. METHODS: All randomized controlled trials assessing the use of antidepressants in generalized anxiety disorder up to may 2002 were included. Non randomized trials and those that included patients with both generalized anxiety disorder and another Axis I co-morbidity were excluded. Relative risks, weighted mean difference and number needed to treat were estimated. People who died or dropped out were regarded as having had no improvement. RESULTS: Antidepressants (imipramine, venlafaxine and paroxetine) were found to be superior to placebo in treating generalized anxiety disorder. The calculated number needed to treat for antidepressants in generalized anxiety disorder was 5.15. Dropout rates did not differ between antidepressants and placebo. CONCLUSION: The available evidence suggests that antidepressants would probably be a reasonable treatment for generalized anxiety disorder patients in the clinical context.info:eu-repo/semantics/openAccessAssociação Brasileira de PsiquiatriaBrazilian Journal of Psychiatry v.27 n.1 20052005-03-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462005000100007en10.1590/S1516-44462005000100007
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Schmitt,Ricardo
Gazalle,Fernando Kratz
Lima,Maurício Silva de
Cunha,Ângelo
Souza,Juliano
Kapczinski,Flávio
spellingShingle Schmitt,Ricardo
Gazalle,Fernando Kratz
Lima,Maurício Silva de
Cunha,Ângelo
Souza,Juliano
Kapczinski,Flávio
The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis
author_facet Schmitt,Ricardo
Gazalle,Fernando Kratz
Lima,Maurício Silva de
Cunha,Ângelo
Souza,Juliano
Kapczinski,Flávio
author_sort Schmitt,Ricardo
title The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis
title_short The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis
title_full The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis
title_fullStr The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis
title_full_unstemmed The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis
title_sort efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis
description OBJECTIVE: To investigate the efficacy and acceptability of antidepressants in the treatment of generalized anxiety disorder. METHODS: All randomized controlled trials assessing the use of antidepressants in generalized anxiety disorder up to may 2002 were included. Non randomized trials and those that included patients with both generalized anxiety disorder and another Axis I co-morbidity were excluded. Relative risks, weighted mean difference and number needed to treat were estimated. People who died or dropped out were regarded as having had no improvement. RESULTS: Antidepressants (imipramine, venlafaxine and paroxetine) were found to be superior to placebo in treating generalized anxiety disorder. The calculated number needed to treat for antidepressants in generalized anxiety disorder was 5.15. Dropout rates did not differ between antidepressants and placebo. CONCLUSION: The available evidence suggests that antidepressants would probably be a reasonable treatment for generalized anxiety disorder patients in the clinical context.
publisher Associação Brasileira de Psiquiatria
publishDate 2005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462005000100007
work_keys_str_mv AT schmittricardo theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT gazallefernandokratz theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT limamauriciosilvade theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT cunhaangelo theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT souzajuliano theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT kapczinskiflavio theefficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT schmittricardo efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT gazallefernandokratz efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT limamauriciosilvade efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT cunhaangelo efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT souzajuliano efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
AT kapczinskiflavio efficacyofantidepressantsforgeneralizedanxietydisorderasystematicreviewandmetaanalysis
_version_ 1756422575149285376